2009
This study aimed to assess outpatient fluoroquinolone (FLQ) use by patients with culture-proven pulmonary TB before diagnosis by linking TB registries in Alberta and Saskatchewan with provincial and federal benefit plans and performing a case-control study to assess FLQ resistance.
Empirical treatment of community-acquired pneumonia and the development of fluoroquinolene-resistant tuberculosis.
Long, R., Chong, H., Hoeppner, V., Shanmuganathan, H., Kowalewska-Grochowska, K., Shandro, C., Manfreda, J. et al. (2009). Empirical treatment of community-acquired pneumonia and the development of fluoroquinolene-resistant tuberculosis. Clinical Infectious Diseases, 48(10), 1354-60.
January 2021
Health Policy Tuberculosis Disease Treatment
January 2020
COVID-19 Pandemic Reponse Disease Prevention Epidemiology Supports and Resources Disease Treatment
COVID-19 Racism, Stigma and Discrimination Disease Prevention Case Management Pandemic Preparedness Testing and Surveillance Disease Treatment
COVID-19 Disease Transmission Testing and Surveillance Disease Treatment